Growth Metrics

Acadia Pharmaceuticals (ACAD) Shareholder's Equity Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 49.40%
Dec 31, 2025 45.26%
Sep 30, 2025 29.16%
Jun 30, 2025 23.66%
Mar 31, 2025 19.82%
Dec 31, 2024 10.65%
Sep 30, 2024 0.60%
Jun 30, 2024 -2.93%
Mar 31, 2024 -7.25%
Dec 31, 2023 -11.69%
Sep 30, 2023 -17.92%
Jun 30, 2023 -15.80%
Mar 31, 2023 -16.31%
Dec 31, 2022 -16.95%
Sep 30, 2022 -14.84%
Jun 30, 2022 3.79%
Mar 31, 2022 2.06%
Dec 31, 2021 4.13%
Sep 30, 2021 36.39%
Jun 30, 2021 28.74%
Mar 31, 2021 24.12%
Dec 31, 2020 23.20%
Sep 30, 2020 20.17%
Jun 30, 2020 16.89%
Mar 31, 2020 11.74%
Dec 31, 2019 10.48%
Sep 30, 2019 6.04%
Jun 30, 2019 -1.65%
Mar 31, 2019 -2.06%
Dec 31, 2018 33.85%
Sep 30, 2018 -0.58%
Jun 30, 2018 1.15%
Mar 31, 2018 2.18%
Dec 31, 2017 2.70%
Sep 30, 2017 4.52%
Jun 30, 2017 5.84%
Mar 31, 2017 7.78%
Dec 31, 2016 41.72%
Sep 30, 2016 47.33%
Jun 30, 2016 31.09%
Mar 31, 2016 77.47%
Dec 31, 2015 32.96%
Sep 30, 2015 134.35%
Jun 30, 2015 172.03%
Mar 31, 2015 153.09%
Dec 31, 2014 136.62%
Sep 30, 2014 127.30%
Jun 30, 2014 120.13%
Dec 31, 2013 83.06%